Virax Biolabs (VRAX) Assets Average (2022 - 2026)
Virax Biolabs (VRAX) posted quarterly Assets Average of $7.4 million for Q1 2026, down 7.05% year-over-year from $7.9 million in Q1 2025, and down 7.05% quarter-over-quarter from $7.9 million in Q1 2025.
Virax Biolabs (VRAX) Assets Average (2022 - 2026) Analysis & Trends
Virax Biolabs' Assets Average history runs 5 years deep, the most recent figure standing at $7.4 million for Q1 2026.
- In Q1 2026, Assets Average fell 7.05% year-over-year to $7.4 million; the TTM figure through Mar 2026 stood at $7.4 million (down 7.05% YoY), while the FY2026 annual figure was $7.4 million, up 23.85% from the prior year.
- Assets Average for Q1 2026 stood at $7.4 million, down from $7.9 million in the prior quarter.
- The five-year high for Assets Average was $7.9 million in Q1 2025, with the low at $44163.5 in Q1 2022.
- The 5-year median for Assets Average is $7.4 million (2024), against an average of $5.9 million.
- The sharpest annual moves came in 2023 and 2026: Assets Average jumped 11064.33% in 2023, then dropped 7.05% in 2026.
- Virax Biolabs' Assets Average stood at $44163.5 in 2022, then surged by 11064.33% to $4.9 million in 2023, then jumped by 51.37% to $7.5 million in 2024, then increased by 6.32% to $7.9 million in 2025, then dropped by 7.05% to $7.4 million in 2026.
- Business Quant data shows VRAX's Assets Average at $7.4 million in Q1 2026, $7.9 million in Q1 2025, and $7.5 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 26.95 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.30 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 11.22 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 8.86 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.34 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.09 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.27 Bn |
| 10 | Virax Biolabs | 1.39 Mn | -5.05 Mn | - | 7.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.38 Mn |
| Mar 31, 2025 | 7.93 Mn |
| Sep 30, 2024 | 7.46 Mn |
| Mar 31, 2024 | 7.65 Mn |
| Mar 31, 2023 | 4.93 Mn |
| Mar 31, 2022 | 44,163.50 |